Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Stopped early

Conditions studied: COVID-19, Acute Respiratory Distress Syndrome

In brief

An informational evaluation of COVID-19 patients who receive low-level laser therapy in addition to a normal regimen of treatment for symptoms associate with COVID-19. Results are compared to statistical observations published in literature from patients receiving standard care for COVID-19 symptoms without low-level laser therapy.

Key facts

Study ID: NCT05258617
Run by: Ward Photonics LLC
People needed: 5
Starts: 2022-02-24
Expected to finish: 2022-11-21
Last updated by the study team: 2022-11-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Participant is diagnosed with COVID-19
Study participant is 18 years of age or older
Patient exhibiting moderate-to-acute respiratory distress

You may not qualify if…

Photosensitive condition or medication
Active chemotherapy treatment or other cancer treatment
Autoimmune Disorder
Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation
Under 18
Active cancer
pre-existing pulmonary disease (asthma chronic bronchitis, emphasema
Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements

Where it is running

MD at Bedside — Berkeley, California, United States
Health Atlast — Los Angeles, California, United States
Longevity — Santa Monica, California, United States
Wellness Junction — Millsboro, Delaware, United States
Diet MD — Honolulu, Hawaii, United States
Diet MD — ‘Ewa Beach, Hawaii, United States
Healing Health Services — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.